Literature DB >> 21324629

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

L Samuel Wann, Anne B Curtis, Kenneth A Ellenbogen, N A Mark Estes, Michael D Ezekowitz, Warren M Jackman, Craig T January, James E Lowe, Richard L Page, David J Slotwiner, William G Stevenson, Cynthia M Tracy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21324629     DOI： 10.1016/j.jacc.2011.01.010

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  53 in total

1.  Concerns about studies investigating new anticoagulant drugs for stroke prevention in atrial fibrillation.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  J Neurol       Date:  2011-11-29       Impact factor: 4.849

2.  Ablation for atrial fibrillation: what are acceptable levels of experience, efficacy, and complications?

Authors:  Kelley P Anderson
Journal:  J Interv Card Electrophysiol       Date:  2012-03-09       Impact factor: 1.900

3.  Spontaneous ascending aortic intramural haematoma in a patient on dabigatran.

Authors:  Stefano Mastrobuoni; James A Robblee; Munir Boodhwani
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-05-21

Review 4.  Oral anticoagulation in atrial fibrillation: balancing the risk of stroke with the risk of bleed.

Authors:  Lynette Kosar; Margaret Jin; Rejina Kamrul; Brenda Schuster
Journal:  Can Fam Physician       Date:  2012-08       Impact factor: 3.275

Review 5.  Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant.

Authors:  Michael Ganetsky; Kavita M Babu; Steven D Salhanick; Robert S Brown; Edward W Boyer
Journal:  J Med Toxicol       Date:  2011-12

6.  Medication management of atrial fibrillation: emerging therapies for rhythm control and stroke prevention.

Authors:  Emily Knapp; Kristin Watson
Journal:  P T       Date:  2011-08

7.  Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, Brazil.

Authors:  Renato D Lopes; Richard C Becker; L Kristin Newby; Eric D Peterson; Elaine M Hylek; Christopher B Granger; Mark Crowther; Tracy Wang; Antonio C Carvalho; Otavio Berwanger; Roberto R Giraldez; Gilson Soares Feitosa; Jorge Pinto Ribeiro; Eduardo Darze; Renato A K Kalil; Marianna Andrande; Fabio Villas Boas; Jadelson Andrade; Ana Thereza Rocha; Robert A Harrington; Antonio C Lopes; David A Garcia
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

Review 8.  Emergency reversal of anticoagulation: novel agents.

Authors:  Michael Levine; Joshua N Goldstein
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

9.  Case report: dabigatran-associated gynecologic bleeding.

Authors:  S Alexander Winans; Adetola Ademolu
Journal:  Hosp Pharm       Date:  2013-03

10.  Massive haemoptysis following dabigatran administration in a patient with bronchiectasis.

Authors:  Manabu Hayama; Hideki Inoue; Hiromichi Wada; Tadashi Mio
Journal:  BMJ Case Rep       Date:  2014-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.